Future studies that will further help in understanding the role of USF‐1 in IR and HDAC inhibitors‐induced signaling in other prostate cancer cells will lead to development of better drugs and treatment strategies for cancer therapy. This evidence concerns the gene HDAC9 and prostate carcinoma.